The search for the fraction of cancer patients who could be eligible for netrin-1 interference-based treatment during early clinical evaluation led us to examine the effects of conventional chemotherapeutic treatments on netrin-1 and netrin-1 receptors expression. The gene discussed is NTN1; the disease is cancer.